Biotech News
Related news
REPLReplimune Group2026-08-19 20:01 EST
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERNGeron2026-08-18 20:01 EST
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERNGeron2026-07-14 20:26 EST
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LYELLyell Immunopharma2026-06-25 12:00 EST
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
SNDXSyndax Pharmaceuticals2026-07-28 11:00 EST
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
REGNRegeneron Pharmaceuticals2026-06-25 20:05 EST
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
Y-mAbs
Y-mAbs Therapeutics is an oncology and rare-disease company focused on antibody-based therapies. Its platform has been built around highly specific biologic treatments for difficult diseases.
Recent company news
YMABY-mAbs2025-09-16 12:41 EST
SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics
YMABY-mAbs2025-08-08 10:35 EST
Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
YMABY-mAbs2025-08-07 11:30 EST
Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
YMABY-mAbs2025-08-05 12:30 EST
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
YMABY-mAbs2025-05-28 10:35 EST
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
Stock data
- Close
- —
- Market cap
- —
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States